Keyphrases
Systemic Lupus Erythematosus
100%
Functional Polymorphism
100%
Coagulation Factor II
100%
African American
36%
Cardiac Events
27%
Caucasian American
27%
Vascular Events
27%
Thrombosis Risk
18%
Allele Frequency
18%
Adjusted Odds Ratio
18%
Prothrombin
18%
Patient-centered
9%
High Risk
9%
Rheumatology
9%
Cardiovascular Events
9%
Systemic Lupus Erythematosus Patient
9%
High Activity
9%
Inflammatory Immune Response
9%
Polymorphism
9%
High Prevalence
9%
Odds Ratio
9%
Gene Polymorphism
9%
Accelerated Atherosclerosis
9%
Activity Measurement
9%
Female Control
9%
Antithrombin Activity
9%
Inflammatory System
9%
G20210A
9%
Antiprothrombin Antibodies
9%
Medicine and Dentistry
Prothrombin
100%
Blood Clotting Factor
100%
Systemic Lupus Erythematosus
100%
Odds Ratio
25%
Thrombosis
16%
Gene Frequency
16%
Allele
16%
Prevalence
8%
Immunity
8%
Hemostat
8%
Cardiovascular System
8%
DNA Polymorphism
8%
Prothrombin Antibody
8%
Rheumatology
8%
Atherosclerosis
8%
Biochemistry, Genetics and Molecular Biology
Blood Coagulation Factor
100%
Prothrombin
100%
Allele
50%
Gene Frequency
50%
Gene Polymorphism
25%
Prevalence
25%
Immunity
25%
Neuroscience
Prothrombin
100%
Blood Clotting Factor
100%
Systemic Lupus Erythematosus
100%
Allele Frequency
16%
Rheumatology
8%
DNA Polymorphism
8%
Prothrombin Antibody
8%
Immunology and Microbiology
Systemic Lupus Erythematosus
100%
Gene Frequency
16%
Allele
16%
Immunity
8%
Prevalence
8%
DNA Polymorphism
8%
Prothrombin Antibody
8%
Atherosclerosis
8%